Phase 4 Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been admitted to hospital for an urgent heart-related condition
- People who are expected to be sent home within the next 48 hours after finishing their hospital treatment
- People who have not yet had a flu vaccine during the current flu season
Who may not be able to join:
- People who have previously had a serious bad reaction to a flu vaccine
- People who are allergic to any ingredient in the flu vaccine being used in this trial
- People who are being transferred to another hospital for ongoing treatment, or moving to a long-term care or nursing facility after leaving hospital
- People who will need to continue taking antibiotics after leaving hospital
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jan Biegus, Professor, Wroclaw Medical University
Phone: 48717364240
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
infection, unplanned cardiovascular hospitalization or cardiovascular death
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.